NYMXF Alzheimer's treatment! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NYMXF Alzheimer's treatment!

NYMXF 0.106

0.0%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ron who wrote (113)	7/30/1998 3:28:00 PM
From: Demetre Deliyanakis	of 132

What were the revenues reported from service fees in the second quarter ? When will the urinary test be made available. The press release is vague. When will human clinical trials of nx-d2858, the lead drug candidate begin?. The cash on hand will pay for approximately 1 year of work at current levels. The company will need more financing if it expects to be able to market the test effectively. I hope that they find a partner with deep pockets soon. The stock has fallen sharply in the past few weeks. I am not sure if today's announcement will push the stock back up to the $10 range.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next